Share-based Payment Arrangement, Expense in USD of Arbutus Biopharma Corp from 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Arbutus Biopharma Corp quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2014 to Q3 2025.
  • Arbutus Biopharma Corp Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $1.2M, a 44.4% decline year-over-year.
  • Arbutus Biopharma Corp Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $4.89M, a 46.1% decline year-over-year.
  • Arbutus Biopharma Corp annual Share-based Payment Arrangement, Expense for 2024 was $8.99M, a 3.39% decline from 2023.
  • Arbutus Biopharma Corp annual Share-based Payment Arrangement, Expense for 2023 was $9.3M, a 29.5% increase from 2022.
  • Arbutus Biopharma Corp annual Share-based Payment Arrangement, Expense for 2022 was $7.18M, a 11.8% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Arbutus Biopharma Corp Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $4.89M $1.2M -$958K -44.4% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $5.85M $764K -$2.42M -76% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $8.27M $1.29M -$721K -35.8% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $8.99M $1.63M -$91K -5.28% 01 Oct 2024 31 Dec 2024 10-K 27 Mar 2025
Q3 2024 $9.08M $2.16M -$323K -13% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 $9.4M $3.18M +$216K +7.29% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 $9.18M $2.01M -$117K -5.49% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $9.3M $1.72M +$56K +3.36% 01 Oct 2023 31 Dec 2023 10-K 27 Mar 2025
Q3 2023 $9.25M $2.48M +$769K +44.9% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 $8.48M $2.96M +$899K +43.5% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $7.58M $2.13M +$395K +22.8% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024
Q4 2022 $7.18M $1.67M +$236K +16.5% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $6.95M $1.71M +$99K +6.13% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 $6.85M $2.07M +$322K +18.5% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023
Q1 2022 $6.53M $1.74M +$101K +6.18% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 $6.42M $1.43M $0 0% 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023
Q3 2021 $6.42M $1.62M -$73K -4.33% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $6.5M $1.74M +$146K +9.14% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022
Q1 2021 $6.35M $1.64M +$190K +13.1% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $6.16M $1.43M +$1.45M 01 Oct 2020 31 Dec 2020 10-K 03 Mar 2022
Q3 2020 $4.71M $1.69M +$172K +11.3% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 $4.54M $1.6M -$2.19M -57.8% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021
Q1 2020 $6.72M $1.45M -$77K -5.06% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021
Q4 2019 $6.8M -$23K 01 Oct 2019 31 Dec 2019 10-K 04 Mar 2021
Q3 2019 $1.52M 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 $3.78M 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020
Q1 2019 $1.52M 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020

Arbutus Biopharma Corp Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $8.99M -$315K -3.39% 01 Jan 2024 31 Dec 2024 10-K 27 Mar 2025
2023 $9.3M +$2.12M +29.5% 01 Jan 2023 31 Dec 2023 10-K 27 Mar 2025
2022 $7.18M +$758K +11.8% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024
2021 $6.42M +$263K +4.27% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023
2020 $6.16M -$638K -9.38% 01 Jan 2020 31 Dec 2020 10-K 03 Mar 2022
2019 $6.8M +$792K +13.2% 01 Jan 2019 31 Dec 2019 10-K 04 Mar 2021
2018 $6.01M -$9.11M -60.3% 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2020
2017 $15.1M -$24M -61.4% 01 Jan 2017 31 Dec 2017 10-K 07 Mar 2019
2016 $39.2M +$17.1M +77.2% 01 Jan 2016 31 Dec 2016 10-K 16 Mar 2018
2015 $22.1M +$18.8M +573% 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018
2014 $3.28M 01 Jan 2014 31 Dec 2014 10-K 22 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.